The market capitalization for TransMedics Group, Inc. (TMDX) is $2.72 Billion, making it a Mid Cap company. Market cap is calculated by multiplying the current stock price by the total number of shares outstanding.
Market Capitalization
$2.72B
$2.72 Billion
Calculation
- Stock Price
- $78.79
- Shares Outstanding
- 34.56M
- Market Cap
- $2.72B
Market Cap = Price × Shares Outstanding
Size Classification
Mid Cap
$2B - $10B
Companies with market capitalization between $2 billion and $10 billion.
Market Cap Size Scale
Micro Cap
<$250M
Small Cap
$250M-$2B
Mid Cap
$2B-$10B
Large Cap
$10B-$1T
Mega Cap
>$1T
Related Valuation Metrics
Key Statistics
| Market Cap | $2.72 Billion |
| Stock Price | $78.79 |
| Shares Outstanding | 34.56M |
| Size Category | Mid Cap |
| P/E Ratio | 18.03 |
| P/B Ratio | 5.77 |
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein